top of page
Katharina_Schlereth.jpg

Dr. Katharina Schlereth

Project A5

Vascular Biology, Medical Faculty Mannheim, Heidelberg University

Vascular Oncology and Metastasis,

German Cancer Research Center, Heidelberg

​

​

katharina.schlereth(at)medma.uni-heidelberg.de

Katharina Schlereth received her PhD at the Philipps-University in Marburg under the supervision of Thorsten Stiewe, where she also pursued postdoctoral training before she moved to the Division of Vascular Oncology and Metastasis at the DKFZ for a senior postdoctoral position.

Qualifications and Scientific Curriculum

2007

2011

2011-2013

since 2013

Diploma: Biology, Julius-Maximilians-University Würzburg, Germany

​

PhD: Molecular Oncology, Philipps-University, Marburg, Germany

​

Postdoctoral research fellow, Division of Molecular Oncology, Philipps-University Marburg, Germany

​

Postdoctoral research fellow, Division of Vascular Oncology and Metastasis, DKFZ, Heidelberg and Department of Vascular Biology, Medical Faculty Mannheim, Heidelberg University, Germany

Ich bin ein Textabschnitt. Klicken Sie hier, um Ihren eigenen Text hinzuzufügen und mich zu bearbeiten.

Selected publications

​​

  1. Schlereth K, Weichenhan D, Bauer T, Heumann T, Giannakouri E, Lipka D, Jaeger S, Schlesner M, Aloy P, Eils R, Plass C, Augustin HG: The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium. eLife. 7:e34423, 2018.

  2. Teichert M, Milde L, Holm A, Stanicek L, Gengenbacher N, Savant S, Ruckdeschel T, Hasanov Z, Srivastava K, Hu J, Hertel S, Bartol A, Schlereth K*, Augustin HG*: Pericyte-expressed Tie2 controls angiogenesis and vessel maturation. Nat Commun. 8:16106, 2017. (*equal contribution)

  3. Schlereth K, Heyl C, Krampitz AM, Mernberger M, Finkernagel F, Scharfe M, Jarek M, Leich E, Rosenwald A, Stiewe T: Characterization of the p53 cistrome-DNA binding cooperativity dissects p53's tumor suppressor functions. PLoS Genet. 9:e1003726, 2013.

  4. Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, Burstain I, Morgenstern Y, Brachya G, Billauer H, Biton S, Snir-Alkalay I, Vucic D, Schlereth K, Mernberger M, Stiewe T, Oren M, Alitalo K, Pikarsky E, Ben-Neriah Y: A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell. 24:242-56, 2013.

  5. Timofeev O, Schlereth K, Wanzel M, Braun A, Nieswandt B, Pagenstecher A, Rosenwald A, Elsässer HP, Stiewe T: p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo. Cell Rep. 3:1512-25, 2013.

  6. Schlereth K*, Beinoraviciute-Kellner R*, Zeitlinger MK, Bretz AC, Sauer M, Charles JP, Vogiatzi F, Leich E, Samans B, Eilers M, Kisker C, Rosenwald A, Stiewe T: DNA binding cooperativity of p53 modulates the decision between cell cycle arrest and apoptosis. Mol Cell. 38:356-68, 2010. (*equal contribution)

  7. Schlereth K, Charles JP, Bretz AC, Stiewe T: Life or death: p53-induced apoptosis requires DNA binding cooperativity. Cell Cycle. 9:4068-76, 2010.

  8. Griesmann H*, Schlereth K*, Krause M, Samans B, Stiewe T: Role of p53 and p73 in suppression of Myc-driven lymphomagenesis. Int J Cancer. 124:502-6, 2009. (*equal contribution)

     

bottom of page